alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 89 Introduced in House (IH)]

<DOC>

119th CONGRESS
  1st Session
                                 H. R. 89

To repeal the authority of the Food and Drug Administration to require 
that drugs be dispensed only upon prescription, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 3, 2025

Mr. Biggs of Arizona introduced the following bill; which was referred 
                to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
To repeal the authority of the Food and Drug Administration to require 
that drugs be dispensed only upon prescription, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prescription Freedom Act of 2025''.

SEC. 2. REPEAL OF FDA AUTHORITY TO REQUIRE PRESCRIPTIONS.

    (a) Repeal.--Effective as of the date that is 6 months after the 
date of enactment of this Act, subsection (b) of section 503 of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353) is repealed.
    (b) References.--Beginning on the effective date described in 
subsection (a), any reference in a Federal statute, regulation, or 
guidance--
            (1) to prescribing, a prescription, a prescription drug, or 
        a drug subject to section 503(b) of the Federal Food, Drug, and 
        Cosmetic Act is deemed to be a reference to prescribing, a 
        prescription, or a prescription drug, respectively, under 
        applicable State law; and
            (2) to any requirement or provision of section 503(b) of 
        the Federal Food, Drug, and Cosmetic Act is deemed to be a 
        reference to the corresponding requirement or provision, if 
        any, in applicable State law, as determined by the Federal 
        official or officials responsible for administering the 
        respective Federal statute, regulation, or guidance.
    (c) Exception.--Notwithstanding subsections (a) and (b), the 
Secretary of Health and Human Services may continue to exercise the 
authority vested by subsection (b) of section 503 of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 353), as in effect on the day before 
the effective date described in subsection (a), with respect to any 
drug that is intended for use in terminating a pregnancy.
                                 <all>
```
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Lakeside  Mortgage Fund, LLC
(the  "Company"),  on Form 10-QSB for the period ended March 31, 2005,  as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I, Placido H. Canta,  Chief Financial Officer of Lakeside Financial Group, Inc.,
the Manager of the Company,  certify,  pursuant to 18 U.S.C. ss.1350, as adopted
pursuant  to  Section  906  of  the  Sarbanes-Oxley  Act of  2002,  that,  to my
knowledge:

         (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.


Dated:   May 13, 2005                       /s/ Placido H. Canta
                                            -------------------------
                                            Placido H. Canta,
                                            Chief Financial Officer of Manager
                                            Lakeside Financial Group, Inc.
Case 3:05-cv-00216-L Document 6 Filed 04/29/05 Page 1 of 2 PageID 34
 

 Case 3:05-cv-00216-L Document 6 Filed 04/29/05 Page 2 of 2 PageID 35
```

[Federal Register Volume 90, Number 9 (Wednesday, January 15, 2025)]
[Notices]
[Page 3978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00794]

-----------------------------------------------------------------------

POSTAL SERVICE

Product Change--Priority Mail Express, Priority Mail, and USPS 
Ground Advantage[supreg] Negotiated Service Agreement

AGENCY: Postal ServiceTM.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Postal Service gives notice of filing a request with the 
Postal Regulatory Commission to add a domestic shipping services 
contract to the list of Negotiated Service Agreements in the Mail 
Classification Schedule's Competitive Products List.

DATES: Date of required notice: January 15, 2025.

FOR FURTHER INFORMATION CONTACT: Sean C. Robinson, 202-268-8405.

SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg] 
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on 
January 6, 2025, it filed with the Postal Regulatory Commission a USPS 
Request to Add Priority Mail Express, Priority Mail & USPS Ground 
Advantage[supreg] Contract 1235 to Competitive Product List. Documents 
are available at www.prc.gov, Docket Nos. MC2025-1052, K2025-1051.

Sean C. Robinson,
Attorney, Corporate and Postal Business Law.
[FR Doc. 2025-00794 Filed 1-14-25; 8:45 am]
BILLING CODE 7710-12-P
```
Cassandra SMITH v. STATE of Louisiana, et al.

No. 2019-C-0225

Supreme Court of Louisiana.

April 8, 2019

**ON WRIT OF CERTIORARI TO THE COURT OF APPEAL, FOURTH CIRCUIT, PARISH OF ORLEANS**

CRICHTON, J., would grant and assigns reasons:

In this trip and fall case I would grant and docket the writ application of State of Louisiana/Department of Transportation and Development (DOTD) to examine whether the plaintiff has presented sufficient factual support to establish the existence of a genuine issue of material fact: whether DOTD "had actual or constructive knowledge of the alleged (rug) defect and failed to take corrective measures within a reasonable time". See La. C.C.P. art. 966(D). See also *Fontenot v. Patterson Ins.* , 2009-0669 (La. 10/20/09), 23 So.3d 259, 268.
# C_2017309EN.01002601.xml

| 18.9.2017 | EN | Official Journal of the European Union | C 309/26 |
| --- | --- | --- | --- |

18.9.2017

EN

Official Journal of the European Union

C 309/26

---

Request for a preliminary ruling from the Corte d’appello di Roma (Italy) lodged on 1 June 2017 — Martina Sciotto v Fondazione Teatro dell’Opera di Roma

(Case C-331/17)

(2017/C 309/32)

Language of the case: Italian

Referring court

Referring court

Corte d’appello di Roma

Parties to the main proceedings

Parties to the main proceedings

Appellant: Martina Sciotto

Appellant:

Respondent: Fondazione Teatro dell’Opera di Roma

Respondent:

Question referred

Question referred

Are the national rules (in particular under Article 3(6) of Decree-Law No 64 of 30 April 2010, converted into law, with amendments, by Law No 100 of 29 June 2010, in so far as they determine that ‘the provisions of Article 1(01) and (2) of Legislative Decree No 368 of 6 September 2008 shall not apply to the operatic and orchestral foundations’) incompatible with Clause 5 of the framework agreement on fixed-term work, concluded on 18 March 1999, which appears in the annex to Council Directive 1999/70/EC (1) of 28 June 1999 concerning the framework agreement on fixed-term work concluded by ETUC, UNICE and CEEP?

the provisions of Article 1(01) and (2) of Legislative Decree No 368 of 6 September 2008 shall not apply to the operatic and orchestral foundations

1

---

(1)  OJ 1999 L 175, p. 43.

1

---
Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Required by Rule 13a-14(a), created by Section 302 of the Sarbanes-Oxley Act of 2002

I, Steven G. Holder,
certify that:

1. I have reviewed this quarterly report on Form 10-Q of ECC Capital Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my
knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;

4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;

b) evaluated the effectiveness of the
registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
evaluation; and

c) disclosed in this report any change in the registrants internal control over financial reporting that
occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal
control over financial reporting; and

5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b) any fraud,
whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Dated: May 15, 2006



/s/ Steven G. HolderSteven G. HolderCo-Chief Executive Officer(Principal Executive Officer)
EX PARTE Darrell Lee JACKSON

CR-16-1003

Court of Criminal Appeals of Alabama.

November 8, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Mand. pet. dismissed.
NOTE: This order is nonprecedential.

United States Court of Appeals 

for the Federal Circuit

__________________________ 

CLARENCE GANAWAY, 

Plaintiff-Appellant, 

v.

UNITED STATES, 

Defendant-Appellee. 

__________________________ 

2013-5031

__________________________

Appeal from the United States Court of Federal 

Claims in No. 12-CV-0654, Judge Francis M. Allegra. 

__________________________ 

ON MOTION

__________________________ 

PER CURIAM. 

O R D E R

Clarence Ganaway moves for reconsideration of the 

court’s February 15, 2013 order dismissing his case for 

failure to pay the required docketing fee, and moves for 

leave to proceed in forma pauperis and for appointment of 

counsel. The United States opposes. 

Case: 13-5031 Document: 13 Page: 1 Filed: 07/01/2013
CLARENCE GANAWAY v. US 2

Pursuant to 28 U.S.C. § 1915(e)(1), this court may appoint an attorney to represent a litigant in federal court, 

but there is no automatic right to appointment of counsel 

in a civil case; the authority is discretionary. See Castro 

Romero v. Becken, 256 F.3d 349, 353-54 (5th Cir. 2001). 

Under the circumstances presented here, we do not see 

the need to exercise this court’s discretion to appoint 

counsel to Mr. Ganaway. 

Accordingly, 

IT IS ORDERED THAT: 

(1) Ganaway is directed to complete and return the 

enclosed “Motion and Declaration for Leave to Proceed In 

Forma Pauperis” and “Supplemental In Forma Pauperis 

Form for Prisoners” forms. If Ganaway does not submit 

the enclosed forms within 30 days from the date of filing 

of this order his motion for reconsideration will be denied. 

(2) Ganaway’s request for appointment of counsel is 

denied. 

FOR THE COURT

 /s/ Daniel E. O’Toole

 Daniel E. O’Toole

 Clerk

cc: Clarence Ganaway (Federal Circuit Forms 6 and 6A 

enclosed) 

s26

Case: 13-5031 Document: 13 Page: 2 Filed: 07/01/2013
STATE of Louisiana v. Kenneth Joseph SMITH

No. 2018-KP-1647

Supreme Court of Louisiana.

April 22, 2019

**ON SUPERVISORY WRITS TO THE TWENTY-SECOND JUDICIAL DISTRICT COURT, PARISH OF ST. TAMMANY**

PER CURIAM:

Denied. Applicant's sentencing claim is not cognizable on collateral review. La.C.Cr.P. art. 930.3 ; *State ex rel. Melinie v. State* , 93-1380 (La. 1/12/96), 665 So.2d 1172 ; *see also* *State v. Cotton* , 09-2397 (La. 10/15/10), 45 So.3d 1030. Applicant also fails to show that he received ineffective assistance of counsel under the standard of *Strickland v. Washington* , 466 U.S. 668, 104 S.Ct. 2052, 80 L.Ed.2d 674 (1984). Finally, applicant fails to show that the state withheld material exculpatory evidence in violation of *Brady v. Maryland* , 373 U.S. 83, 83 S.Ct. 1194, 10 L.Ed.2d 215 (1963).

Applicant has now fully litigated his application for post-conviction relief in state court. Similar to federal habeas relief, *see* 28 U.S.C. § 2244, Louisiana post-conviction procedure envisions the filing of a second or successive application only under the narrow circumstances provided in La.C.Cr.P. art. 930.4 and within the limitations period as set out in *1111La.C.Cr.P. art. 930.8. Notably, the legislature in 2013 La. Acts 251 amended that article to make the procedural bars against successive filings mandatory. Applicant's claims have now been fully litigated in accord with La.C.Cr.P. art. 930.6, and this denial is final. Hereafter, unless he can show that one of the narrow exceptions authorizing the filing of a successive application applies, applicant has exhausted his right to state collateral review. The district court is ordered to record a minute entry consistent with this per curiam.
EX PARTE Jerry Lewis PRICE

CR-17-0059

Court of Criminal Appeals of Alabama.

October 23, 2017

Mand. pet. dismissed.
Guy Dewitt CHAPPELL III v. ALABAMA STATE BAR

1151311

Supreme Court of Alabama.

August 25, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 32.1





Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In connection with the quarterly report of On4 Communication, Inc. (the "Company") on Form 10-Q for the period ended January 31, 2011 as filed with the Securities and Exchange Commission (the "Report"), I, Cameron Robb, in the capacities and on the date indicated below, certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








Dated:  March 22, 2011





By:        /s/ Cameron Robb


Cameron Robb


Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer, Director
# C_2016305EN.01004701.xml

| 22.8.2016 | EN | Official Journal of the European Union | C 305/47 |
| --- | --- | --- | --- |

22.8.2016

EN

Official Journal of the European Union

C 305/47

---

Action brought on 28 June 2016 — Flatworld Solutions/EUIPO — Outsource2India (Outsource 2 India)

(Case T-340/16)

(2016/C 305/63)

Language in which the application was lodged: English

Parties

Parties

Applicant: Flatworld Solutions Pvt. Ltd (Bangalore, India) (represented by: S. Gillert, K. Vanden Bossche, B. Köhn-Gerdes, J. Schumacher, lawyers)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Other party to the proceedings before the Board of Appeal: Outsource2India Ltd (Friedrichshafen, Germany)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Proprietor of the trade mark at issue:

Trade mark at issue: EU figurative mark containing the word elements ‘Outsource 2 India’ — EU trade mark No 6 035 547

Trade mark at issue:

Procedure before EUIPO: Proceedings for a declaration of invalidity

Procedure before EUIPO

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 15 April 2016 in Case R 611/2015-4

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision in its entirety; |
| --- | --- |

—

annul the contested decision in its entirety;

| — | confirm the decision of the Cancellation Division of 3 February 2015; |
| --- | --- |

—

confirm the decision of the Cancellation Division of 3 February 2015;

| — | order EUIPO to pay the costs including the costs incurred by the Applicant. |
| --- | --- |

—

order EUIPO to pay the costs including the costs incurred by the Applicant.

Plea in law

Plea in law

| — | Infringement of Article 52(1)(b) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 52(1)(b) of Regulation No 207/2009.

---
EX PARTE Robert LITTLETON III

1160788 (CR-16-0390)

Supreme Court of Alabama.

July 7, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Cert. denied.
Exhibit 10.15

                              ADZONE RESEARCH, INC.
    4062-80 Grumman Blvd. Calverton, NY 11933 631-369-1100 FAX: 631-369-4024
--------------------------------------------------------------------------------

                      BOARD MEETING MINUTES AND RESOLUTION

On March 7, 2003 the board of directors of AdZone Research, Inc. had a meeting
via conference telephone where by the following directors were present

John Cardona, Charles Cardona, Warren Hamburger

Absent was:  Russell Ivy

The board resolved to approve obtaining a Loan from Financial Engineering, Inc.
(Al Morrison) of 1301 S. Odell Street, Brownsburg, Indiana 317-852-4233. Charles
Cardona and John Cardona have agreed to allow 8 Million shares of their stock to
be pledged as collateral for this loan in the following amounts.

Charles Cardona will pledge 3,908,151 shares
John Cardona will pledge 4,091,849 shares

They have agreed to pledge these unrestricted shares in exchange for the same
number of newly issued shares. Should the company be unable to return the shares
in 1 year, the company will also be obligated to replace the shares pledged with
S-8 shares in addition to the exchange shares.

The Board resolved to issue 3,908,151 shares of restricted common stock to:

Charles Cardona for the use of his unrestricted shares as collateral, and

The Board resolved to issue 4,091,849 shares of restricted common stock to:

John Cardona for the use of his unrestricted shares as collateral

The company does not wish to unduly enrich the persons pledging the stock,
therefore the company will have the right to re-purchase these shares at any
time prior to March 31, 2004 for 10.5 cents per share. The shares must be
repurchased in a single block.

The directors present voted unanimously for the issuance of the stock, this
resolution and the attached contract.


Affirmed by:
            --------------------------


--------------------------                     --------------------------
Name:                                                     Title

--------------------------
Date
<PAGE>
                                    AGREEMENT

Between AdZone Research, Inc. and

Charles Cardona and John Cardona
Charles Cardona agrees to pledge 3,908,151 shares of his stock and

John Cardona agrees to pledge 4,091,849 shares of his stock as collateral for a
loan for AdZone Research.

As the pledged stock has no legend, the company agrees to compensate Charles
Cardona and John Cardona as follows:

The Board resolved to issue 3,908,151 shares of restricted common stock to:

Charles Cardona for the use of his unrestricted shares as collateral, and

The Board resolved to issue 4,091,849 shares of restricted common stock to:

John Cardona for the use of his unrestricted shares as collateral

The company will have the right to re-purchase these shares at any time prior to
March 31, 2004 for 10.5 cents per share. The shares must be repurchased in a
single block.

Agreed to:


----------------------
AdZone Research, Inc.


----------------------
John Cardona


----------------------
Charles Cardona


----------------------
Date
Exhibit 32.1



18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of GlobalSantaFe Corporation (the Company) on Form 10-K for the year ended December 31, 2004, as filed with the
Securities and Exchange Commission (the Report), I, Jon A. Marshall, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Jon A. Marshall

---

Jon A. Marshall

Chief Executive Officer

March 1, 2005